Proactive Investors - Run By Investors For Investors

Physiomics lands pre-clinical contract for virtual tumour tech

Physiomics' Virtual Tumour is a sophisticated computer model that simulates tumour cell division
tumour
Contract wlil be for pre-clinical work

Physiomics Plc (LON:PYC) has been awarded another pre-clinical contract for its Virtual Tumour technology.

The contract is worth £35,000 and with an unnamed major pharma group.

READ: Physiomics and Merck team up to progress Virtual Tumour technology

Physiomics' Virtual Tumour is a sophisticated computer model that simulates tumour cell division and predicts the effect of different anti-cancer regimes.

The modelling helps with efficacy and toxicity and identifies the best drug combinations. 

Jim Millen, chief executive, said: "We are delighted to be working with a significant new client.  If this initial project is successful, we would hope to develop a longer-term relationship."

In November, Physiomics completed a  human Virtual Tumour project with Merck following which it signed a master services agreement with the German pharma giant.

View full PYC profile View Profile

Physiomics Plc Timeline

Related Articles

test tubes
May 07 2019
Here we take a closer look at Arix Biosciences PLC (LON:ARIX), a listed venture capital company that doesn’t appear to be receiving the recognition it deserves
PT exercises
December 19 2018
The Californian company is a bet on an industry that is in need of transformation
cancer scans
July 05 2019
Here we take a closer look at Physiomics, the AIM company that owns a piece of software called Virtual Tumour that predicts the effects of drugs on cancers

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use